# An Observational Study of Pegasys (Peginterferon Alfa-2a) Plus Ribavirin Based Regimens in Patients With Chronic Hepatitis C With Previous Treatment Failure

> **NCT01798576** · — · TERMINATED · sponsor: **Hoffmann-La Roche** · enrollment: 282 (actual)

## Conditions studied

- Hepatitis C, Chronic

## Interventions

- **DRUG:** Pegylated Interferon alfa-2a
- **DRUG:** Ribavirin

## Key facts

- **NCT ID:** NCT01798576
- **Lead sponsor:** Hoffmann-La Roche
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** TERMINATED
- **Start date:** 2012-11
- **Primary completion:** 2015-06
- **Final completion:** 2015-06
- **Target enrollment:** 282 (ACTUAL)
- **Last updated:** 2016-09-15


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01798576

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01798576, "An Observational Study of Pegasys (Peginterferon Alfa-2a) Plus Ribavirin Based Regimens in Patients With Chronic Hepatitis C With Previous Treatment Failure". Retrieved via AI Analytics 2026-06-08 from https://api.ai-analytics.org/clinical/NCT01798576. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*